免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission

NCT:NCT07866872 · ENROLLING_BY_INVITATION

NCT IDNCT07866872
狀態ENROLLING_BY_INVITATION
開始日期2026-06-17
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

簡要摘要

The investigators are examining how adding relative blood volume monitoring (RBVM) to the best clinical practice affects outcomes (length of stay and rehospitalization) among dialysis patients hospitalized for or with volume overload.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑